Glenmark Pharmaceuticals Receives ANDA Approval for Clobetasol Propionate Foam, 0.05% (Emulsion Formulation)

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Foam, 0.05% (Emulsion Formulation), a generic version of Olux®1-E Foam, 0.05%, of Mylan Pharmaceuticals Inc.

According to IQVIA™ sales data for the 12 month period ending July 2019, the Olux®-E Foam, 0.05% market2achieved annual sales of approximately $11.1 million*.

Glenmark's current portfolio consists of 161 products authorized for distribution in the U.S. marketplace and 54 ANDA's pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

1All brand names and trademarks are the property of their respective owners.

2Market includes brand and all available therapeutic equivalents

*IQVIA™ National Sales Perspectives: Retail & Non-Retail, July 2019

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical organization. It is ranked among the top 80 Pharma & Biotech companies of the world in terms of revenue (SCRIP 100 Rankings published in the year 2019). Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is focused in the areas of oncology, dermatology and respiratory.

The company has a significant presence in the branded generics markets across emerging economies including India. Glenmark has 16 manufacturing facilities across five countries and has six R&D centers. The Generics business of Glenmark services the requirements of the US and Western European markets. The API business sells its products in over 80 countries, including the US, various countries in the EU, South America and India.

Tags : #glenmarkpharmaceuticals

Related Stories

07 Sep

JNCASR researchers develop diagnostic therapy for Lung Cancer

Now a safe and cheap way for determining lungs cancer

View
29 Aug

Citriodiol in insect repellent may protect against COVID-19: UK study

Citriodiol had anti-viral properties if mixed with the virus in the liquid phase and on a test surface

View
05 Aug

INST develops new kit to detect fluoride in drinking water

Equipment-free, a simple paper-strip based naked-eye fluoride ion detection and quantification kit in drinking water to evade Fluorosis-based disorders

View
29 Jul

SNBNCBS develops a device for screening of bilirubin level in new born

The operation of the device is based on non-contact and non-invasive spectrometry-based techniques for measurement of neonatal bilirubin level

View
17 Jul

ARCI & Vehant Technologies co-develop UV System for baggage

ARCI & Vehant Technologies co-develop UV System for baggage Scan Disinfection to fight COVID 19

View
15 Jul

Atal Innovation Mission to support Startups with COVID-19 Solutions

9 startups were chosen in the first round for funding

View
26 May

Molecular shock absorbers buffer axonal tension of nerve cells : RRI

Department of Science &Technology along with IISER Pune have proved Spectrin act as ‘shock absorbers’

View
14 May

DST initiatives to protect Divyangjan and Elderly

PSG College of Technology

View
13 Apr

IUSSTF boosts Indo-US virtual networks to address COVID 19 challenges

Collaboration across nations and organizations can leverage and share expertise across S&T communities and facilitate the development of a diverse, globally-engaged science, engineering, and technology-abled workforce, which can proactively work towards solutions for the Pandemic

View
07 Apr

Chandigarh University Uses 3D Printing Technology to Design Splitters That can Bridge Ventilators Shortfall in India

Chandigarh University had constituted a Core Research Group on the call made by Department of Science and Technology (DST) which had invited proposals from companies

View

-Advertisements-




Trending Now

Will India’s Healthcare Budget Support a Future of Robotic Surgeries?February 22, 2025
Is the World on the Brink of Another Pandemic? Scientists Discover a New Bat VirusFebruary 22, 2025
Newcastle University Expands Academic and Research Collaborations in IndiaFebruary 21, 2025
Get Ready to #BibaUp! Kriti Sanon Unveils the Season’s Most Stylish Summer CollectionFebruary 21, 2025
A Rare Condition: Surgery Saves 2-Day-Old Baby as Organs Shift Into ChestFebruary 21, 2025
Odisha’s Bold Healthcare Vision: A Rs 12,000 Crore Blueprint for Universal Health AccessFebruary 21, 2025
Young India’s Health Crisis: Why Insurance Claims Are Rising Among 25-35 Year OldsFebruary 21, 2025
India vs. Trump’s Pharma Tariff: The Battle Over Affordable MedicineFebruary 21, 2025
Foreign Medical Aspirants in Trouble: NMC’s Warning on Pending Eligibility CertificatesFebruary 21, 2025
Think Your Work Music Helps You Focus? Science Says Think AgainFebruary 21, 2025
Is Your Home’s Air Poisoning You? Shocking New Study Reveals Hidden Indoor Pollution RisksFebruary 20, 2025
The Society of Automotive Engineers & B V Raju Institution of Technology; to host the globally prestigious E-BAJA 2025; at Hyderabad!February 20, 2025
Eat right for your heart to beat rightFebruary 19, 2025
Aakash Healthcare and Medtronic Inaugurate North India’s First Dedicated Vein ClinicFebruary 19, 2025
Urgent and accelerated HIV service delivery with equity and rights is critical to end AIDSFebruary 19, 2025
Fasting Fad or Future Health Threat? Why Teens Should Think Twice Before Intermittent Fasting February 19, 2025
Public Hospitals Go High-Tech: AIIMS Delhi Leads India’s Robotic Surgery WaveFebruary 19, 2025
Screen Time and Healthy Habits: Navigating Optimal Development in ChildrenFebruary 18, 2025
SRM Global Hospitals Launches WOW, a Centre Exclusively for Women’s Health and WellnessFebruary 18, 2025
The Hidden Dangers of Scented Candles: Aesthetic Bliss or Silent Health Hazard?February 18, 2025